Updates in HER2-directed Therapies in Solid Tumors
Activity Description:
This microlearning activity is designed to help pathologists, laboratory professionals, and other members of the cancer care team gain an understanding of emerging research in pan-tumor HER2 testing in patients with advanced solid tumors and of treatment options based on HER2 results. This activity will also address designing laboratory workflows to achieve efficient, accurate, and equitable pan-tumor HER2 testing. The microlearning design of this activity allows for a brief and focused exploration of this topic.
Course topics include:
HER2 signaling pathway
HER2 amplification and overexpression and its prevalence in various solid tumors
DESTINY-PanTumor02 and the recent FDA pan-tumor approval
HER2 IHC scoring guidelines
Specimen handing and biomarker reporting
HER2 IHC with different antibodies and tumor heterogeneity
Treatment implications for patients based on HER2 results
Faculty/Authors Wei Zhang, MD, PhD Associate Professor, Medical Director of Molecular Pathology (Solid Tumor) Department of Pathology and Laboratory Medicine, University of Kansas Medical Center Kansas City, Kansas
Physician's Competency: Patient Care, Medical Knowledge, Practice-Based Learning and Improvement CME/CMLE Credit: 0.25Estimated Completion Time: 0.25 hourFormat: Online educational activity
Target Audience
This activity has been designed to meet the educational needs of pathologists and laboratory professionals.
Credit Designation Statement
The ASCP designates this activity for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
ASCP designates this activity for a maximum of .25 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT.
Method of Participation
To complete the activity and receive credit, the participant must have participated in the course. CME certificates will be provided online
Commercial Support
This activity is supported by independent educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc.
Instructions
To claim CME/CMLE credit for the exercise, do the following:
Upon completion of this activity, you will be able to: